Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets

Ubiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small...

Full description

Bibliographic Details
Main Authors: Emil Bulatov, Almaz Zagidullin, Aygul Valiullina, Regina Sayarova, Albert Rizvanov
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00450/full
id doaj-3eda039980734e2dbf6eb0aff16bb374
record_format Article
spelling doaj-3eda039980734e2dbf6eb0aff16bb3742020-11-24T23:15:50ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-05-01910.3389/fphar.2018.00450344951Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as TargetsEmil Bulatov0Almaz Zagidullin1Aygul Valiullina2Regina Sayarova3Albert Rizvanov4Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, RussiaA.E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center, Russian Academy of Sciences, Kazan, RussiaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, RussiaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, RussiaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, RussiaUbiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small molecule modulation is reinforced by ever growing evidence of their role in cancer and other diseases. To date the number of potent compounds targeting E3 ligases remains rather low and their rational design constitutes a challenging task. To successfully address this problem one must take into consideration the multi-subunit nature of many E3 ligases that implies multiple druggable pockets and protein–protein interfaces. In this review, we briefly cover the current state of drug discovery in the field of RING-type E3 ligases with focus on MDM and Cullin families as targets. We also provide an overview of small molecule chimeras that induce RING-type E3-mediated proteasomal degradation of substrate proteins of interest.http://journal.frontiersin.org/article/10.3389/fphar.2018.00450/fullubiquitin–proteasome systemRING-type E3 ligasesMDM familyCullin familysmall moleculesinduced protein degradation
collection DOAJ
language English
format Article
sources DOAJ
author Emil Bulatov
Almaz Zagidullin
Aygul Valiullina
Regina Sayarova
Albert Rizvanov
spellingShingle Emil Bulatov
Almaz Zagidullin
Aygul Valiullina
Regina Sayarova
Albert Rizvanov
Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
Frontiers in Pharmacology
ubiquitin–proteasome system
RING-type E3 ligases
MDM family
Cullin family
small molecules
induced protein degradation
author_facet Emil Bulatov
Almaz Zagidullin
Aygul Valiullina
Regina Sayarova
Albert Rizvanov
author_sort Emil Bulatov
title Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
title_short Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
title_full Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
title_fullStr Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
title_full_unstemmed Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
title_sort small molecule modulators of ring-type e3 ligases: mdm and cullin families as targets
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-05-01
description Ubiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small molecule modulation is reinforced by ever growing evidence of their role in cancer and other diseases. To date the number of potent compounds targeting E3 ligases remains rather low and their rational design constitutes a challenging task. To successfully address this problem one must take into consideration the multi-subunit nature of many E3 ligases that implies multiple druggable pockets and protein–protein interfaces. In this review, we briefly cover the current state of drug discovery in the field of RING-type E3 ligases with focus on MDM and Cullin families as targets. We also provide an overview of small molecule chimeras that induce RING-type E3-mediated proteasomal degradation of substrate proteins of interest.
topic ubiquitin–proteasome system
RING-type E3 ligases
MDM family
Cullin family
small molecules
induced protein degradation
url http://journal.frontiersin.org/article/10.3389/fphar.2018.00450/full
work_keys_str_mv AT emilbulatov smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets
AT almazzagidullin smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets
AT aygulvaliullina smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets
AT reginasayarova smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets
AT albertrizvanov smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets
_version_ 1725589290636804096